Duality Advisers, LP United Therapeutics Corp Transaction History

Duality Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$210.76 - $249.51 $446,811 - $528,961	-2,120 Reduced 13.55%	13,522 $3.11 Million
Q4 2023 Feb 01, 2024	BUY	$214.88 - $256.94 $1.21 Million - $1.44 Million	5,622 Added 56.11%	15,642 $3.44 Million
Q3 2023 Nov 02, 2023	SELL	$211.82 - $248.24 $183,012 - $214,479	-864 Reduced 7.94%	10,020 $2.26 Million
Q2 2023 Jul 31, 2023	BUY	$205.19 - $232.99 $494,918 - $561,971	2,412 Added 28.47%	10,884 $2.4 Million
Q1 2023 Jun 27, 2023	BUY	$212.99 - $276.17 $1.8 Million - $2.34 Million	8,472 New	8,472 $1.9 Million
Q2 2022 Aug 08, 2022	SELL	$174.81 - $241.14 $1.83 Million - $2.52 Million	-10,458 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$166.16 - $213.96 $1.47 Million - $1.89 Million	8,842 Added 547.15%	10,458 $1.88 Million
Q4 2021 Feb 02, 2022	SELL	$184.32 - $216.08 $2.97 Million - $3.48 Million	-16,122 Reduced 90.89%	1,616 $349,000
Q3 2021 Nov 08, 2021	BUY	$179.86 - $214.88 $2.84 Million - $3.39 Million	15,770 Added 801.32%	17,738 $3.27 Million
Q2 2021 Aug 09, 2021	SELL	$170.47 - $211.93 $84,894 - $105,541	-498 Reduced 20.19%	1,968 $353,000
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $635,002 - $721,256	-4,125 Reduced 62.59%	2,466 $412,000
Q4 2020 Feb 09, 2021	SELL	$101.87 - $151.79 $570,370 - $849,872	-5,599 Reduced 45.93%	6,591 $1 Million
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $1.22 Million - $1.48 Million	12,190 New	12,190 $1.23 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.